Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

Aastrom

Started by caliban , Sep 09 2009 06:58 PM

Page 4 of 6
2
3
4
5
6

Please log in to reply

150 replies to this topic

#91 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 25 October 2011 - 08:55 AM

6 Biotech Stocks Undervalued By Their Levered Free Cash Flows
Seeking Alpha - 7 hours ago

Contrary to what you may expect, many publicly traded biotech firms do not yet produce significant cash flows. This is because many biotechs are developing products but do not yet have a drug on ...

View the full article

#92 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 25 October 2011 - 04:11 PM

Regenerative Medicine Marches Ahead (CUR, ASTM, ACTC)
SmallCap Network - 3 hours ago

By Dennis Askew Neuralstem, Inc. (AMEX:CUR) has had an exceptional October and other stem cell therapeutic companies like Aastrom Biosciences, Inc. (NASDAQ:ASTM) and Advanced Cell Technology, Inc ...

View the full article

#93 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 25 October 2011 - 04:11 PM

Regenerative Medicine Marches Ahead (CUR, ASTM, ACTC)
SmallCap Network - 10 hours ago

By Dennis Askew Neuralstem, Inc. (AMEX:CUR) has had an exceptional October and other stem cell therapeutic companies like Aastrom Biosciences, Inc. (NASDAQ:ASTM) and Advanced Cell Technology, Inc ...

View the full article

#94 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 25 October 2011 - 04:11 PM

Regenerative Medicine Marches Ahead (CUR, ASTM, ACTC)
SmallCap Network - 21 hours ago

By Dennis Askew Neuralstem, Inc. (AMEX:CUR) has had an exceptional October and other stem cell therapeutic companies like Aastrom Biosciences, Inc. (NASDAQ:ASTM) and Advanced Cell Technology, Inc ...

View the full article

#95 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 31 October 2011 - 08:06 PM

Webcast Alert: Aastrom to Host Third Quarter 2011 Investor Call on Tuesday, November 8, 2011
MarketWatch - 2 hours ago

ANN ARBOR, Mich., Oct 31, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -1.54% , the leading developer of patient-specific, expanded ...

View the full article

#96 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 01 November 2011 - 08:08 PM

Final 12-Month Results From the Aastrom RESTORE-CLI Phase 2b Clinical Trial to be Presented at the American Heart Association Scientific Sessions 2011 on Monday, November 14, 2011
MarketWatch - 3 hours ago

ANN ARBOR, Mich., Nov 1, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -4.30% , the leading developer of patient-specific, expanded ...

View the full article

#97 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 02 November 2011 - 03:05 PM

Analysts' New Coverage for November, 2nd (AGCO, ARUN, ASTM, ASX, BLTI, CAT, CMP, DE, FFIV, IPI, JOYG, MMS, MON, OMG, SPIL, ST, SYY, XYL)
LocalizedUSA - 1 hour ago

AGCO Corp. (NASDAQ: AGCO) is now covered by analysts at Morgan Stanley. The analysts set an â€œunderweightâ€ rating on the stock. Aruba Networks, Inc. (NASDAQ: ARUN) is now covered by analysts at JMP ...

View the full article

#98 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 01 November 2011 - 08:08 PM

ANN ARBOR, Mich., Nov 1, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +4.90% , the leading developer of patient-specific, expanded ...

Chardan Capital Markets Analysts Now Covering Aastrom Biosciences Inc (ASTM) Stock - LocalizedUSA

View the full article

#99 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 02 November 2011 - 06:09 PM

Analysts' Ratings: ASPS, ASTM, ASX, ATML, BGS, BHI, BKS, BLTI, BNCN, BPI, BTUI, CAT, CBB, CBL, CCG
Jags Report - 2 hours ago

Zacks Investment Research upgraded shares of Altisource Portfolio (ASPS) from a â€œneutralâ€ rating to an â€œoutperformâ€ rating. Chardan Capital Markets initiated coverage on shares of Aastrom ...

View the full article

#100 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 03 November 2011 - 01:21 PM

New York Academy of Sciences Symposium on Advances in Adult Stem Cell Therapy in Tissue Repair for Cardiovascular Diseases to Feature Aastrom Biosciences
TradersHuddle.com - 22 minutes ago

ANN ARBOR, Mich., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe ...

View the full article

#101 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 03 November 2011 - 12:03 PM

SYSCO (SYY) (ST) (XYL) (AGCO) (ARUN) (ASTM) Get New Coverage
Everything Gold - 1 hour ago

SYSCO Co. (NYSE: SYY), Sensata Tech (NYSE: ST), Xylem (NYSE: XYL), AGCO Corp. (NASDAQ: AGCO), Aruba Networks, Inc. (NASDAQ: ARUN) and Aastrom Biosciences Inc. (NASDAQ: ASTM) getting new coverage ...

View the full article

#102 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 08 November 2011 - 01:11 PM

ASTM, ARAY, ATVI, ALSK, ALEX, DOX are Releasing Earnings November-8
Beacon Equity Research - 3 hours ago

Aastrom Biosciences Inc (ASTM). Aastrom Biosciences, Inc. is regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple ...

View the full article

#103 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 08 November 2011 - 08:24 PM

Aastrom Biosciences Reports Third Quarter 2011 Financial Results
MarketWatch - 2 hours ago

ANN ARBOR, Mich., Nov 8, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +1.53% , the leading developer of patient-specific expanded ...

Aastrom Biosciences (ASTM), Reminder, Q3/11 Investor Call - Proactive Investors USA & Canada

View the full article

#104 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 09 November 2011 - 04:44 PM

Aastrom Biosciences Q3/11 Earnings Results
Seeking Alpha - 11 minutes ago

Aastrom (ASTM) reported a Q3/11 net loss of $1.9M, or $0.05 per share, compared to a net loss of $5.9M, or $0.21 per share for Q3/10. Revenue was $9K. Cost of product was $2K. R&D expenses for Q3 ...

View the full article

#105 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 09 November 2011 - 03:46 PM

Beats And Misses: (CHKM), (ACRX), (ASTM), (ACHN), (SAJA)
Takeover Chatter - 1 hour ago

Chesapeake Midstream Partners, Lp (CHKM) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $0.29 per share, and the company reported $0 ...

View the full article

#106 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 08 November 2011 - 08:24 PM

Aastrom Biosciences Reports Third Quarter 2011 Financial Results
MarketWatch - 20 hours ago

ANN ARBOR, Mich., Nov 8, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -1.12% , the leading developer of patient-specific expanded ...

Aastrom Biosciences (ASTM), Reminder, Q3/11 Investor Call - Proactive Investors USA & Canada

View the full article

#107 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 08 November 2011 - 08:24 PM

Aastrom Biosciences Reports Third Quarter 2011 Financial Results
MarketWatch - Nov 8, 2011

ANN ARBOR, Mich., Nov 8, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -1.12% , the leading developer of patient-specific expanded ...

Aastrom Biosciences (ASTM), Reminder, Q3/11 Investor Call - Proactive Investors USA & Canada
Aastrom Biosciences Q3/11 Earnings Results - Seeking Alpha

View the full article

#108 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 11 November 2011 - 08:22 PM

Regenerative Medicine Universe Earnings Report Card Q3/11
Seeking Alpha - 4 hours ago

An earnings release is a "report card" of sorts for a public stem cell company. The current LPS (loss per share) standings reflect the universes' investing status. By analyzing these comparisons ...

View the full article

#109 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 11 November 2011 - 06:48 PM

Aastrom Biosciences (ASTM) Higher Ahead of Data
StreetInsider.com - 6 hours ago

Shares of Aastrom Biosciences (NASDAQ: ASTM) are seeing action Friday after the stock was highlighted as the "next big thing in biotech" by theStreet.com's Adam Feuerstein. Feuerstein put the ...

View the full article

#110 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 11 November 2011 - 06:20 PM

InVivo's Innovative Instigation In Spinal Cord Injury
Seeking Alpha - 6 hours ago

In the United States alone, 1,275,000 people are living with paralysis as a result of spinal cord injury (SCI). Each year, about 12,000 other people are added to that count [1]. In 1992, Mr. Frank ...

View the full article

#111 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 11 November 2011 - 05:53 PM

12 Stocks Under $5 Undervalued By Levered Free Cash Flow
Seeking Alpha - 7 hours ago

For ideas on how to find potentially undervalued stocks, here's a list you may find interesting. One ratio that can compare company valuations is levered free cash flow/enterprise value. The ...

View the full article

#112 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 11 November 2011 - 10:44 AM

VistaGen Therapeutics Represents Growing Field Of Cell-Based Therapy
Seeking Alpha - 14 hours ago

Note: We have received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (VSTA.OB). Readers should be aware that this ...

View the full article

#113 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 10 November 2011 - 02:31 AM

Healthcare Sector Review: Winning and Losing Stocks on Nov 9th
Wall St. Cheat Sheet - Nov 10, 2011

By Stella Mariz Gentiva Health Services (NASDAQ:GTIV): The shares closed at $5.34, up $0.79, or 17.36%, on the day. Its market capitalization is $163.45 million. About the company: Gentiva Health ...

View the full article

#114 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 14 November 2011 - 04:15 PM

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T in Patients with Critical Limb Ischemia
MarketWatch - 3 hours ago

ANN ARBOR, Mich., Nov 14, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -6.55% , the leading developer of patient-specific, expanded ...

Aastrom Cell Therapy Reverses Effects of Blocked Leg Arteries - TheStreet.com
Aastrom's cell therapy shows promise in trial - Reuters
Bloomberg- StreetInsider.com- RTT News

View the full article

#115 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 14 November 2011 - 11:00 PM

Biotech Uncertainty = Big Upside Potential
Motley Fool - 3 hours ago

By Brian Orelli | More Articles Ever sit in the upper deck of a large ballpark and see a high fly ball that you thought was going out of the park, only to see it die well before the warning track ...

View the full article

#116 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 16 November 2011 - 01:18 PM

Breakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain Ground
MarketWatch - 11 minutes ago

NEW YORK, NY, Nov 16, 2011 (MARKETWIRE via COMTEX) -- The case for increased stem cell funding is growing by the day as the potentially lifesaving effects of regenerative medicine continue to be ...

View the full article

#117 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 15 November 2011 - 07:06 PM

Breakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain Ground
MarketWatch - 21 hours ago

NEW YORK, NY, Nov 16, 2011 (MARKETWIRE via COMTEX) -- The case for increased stem cell funding is growing by the day as the potentially lifesaving effects of regenerative medicine continue to be ...

The Beneficiaries of Geron's Exit From Stem Cell Therapy - Seeking Alpha

View the full article

#118 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 22 November 2011 - 09:05 PM

Aastrom Biosciences to Present at Piper Jaffray 23rd Annual Health Care Conference in New York City
MarketWatch - 19 hours ago

ANN ARBOR, Mich., Nov 22, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -1.79% , the leading developer of patient-specific, expanded ...

View the full article

#119 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 09 January 2012 - 01:23 PM

Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012
MarketWatch - 2 hours ago

NEW YORK, NY, Jan 09, 2012 (MARKETWIRE via COMTEX) -- Stem Cell stocks -- particularly companies focused on adult stems cells -- have performed well of late. Earlier this month Goldman Sachs noted ...

View the full article

#120 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 12 January 2012 - 04:43 PM

Investors Waiting For Aastrom To Raise Cash
Seeking Alpha - 56 minutes ago

Shares of Aastrom Biosciences (ASTM) have declined nearly 30% over the past two months, despite what we view as very positive results from the company's phase 2b RESTORE-CLI trial.

View the full article